CERE   $44.96  0.76% Market Closed

Cerevel Therapeutics Holdings Inc
Total Cash 846.29M
totalCashPerShare 4.645
EBITDA -484.52M
Total Debt 482.30M
quickRatio 10.121
currentRatio 10.22
Total Revenue
debtToEquity 85.445
Revenue/Share
ROA -0.29789
ROE -0.92447996
grossProfits
freeCashflow -212.07M
operatingCashflow -367.05M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 7.83B
forwardPE -15.39726
floatShares 77.82M
sharesOutstanding 182.20M
sharesShort 5.98M
sharesShortPriorMonth 6.36M
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.15%
heldPercentInstitutions 0.85%
Short Ratio help_outline 2.37%
shortPercentOfFloat 0.07%
impliedSharesOutstanding
bookValue 3.103
Price To Book help_outline 14.49
earningsQuarterlyGrowth
netIncomeToCommon -460.47M
trailingEps -2.73%
forwardEps -2.92%
enterpriseToEbitda -16.16
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.8 2Q 2024
institutionsCount 283
lastUpdated Aug. 18, 2024, 3:32 p.m.